Skip to main content
Premium Trial:

Request an Annual Quote

DiscoveRx to Provide Cell-Based Assay Platform for NIH Chemical Genomics Program

NEW YORK, Nov. 4 (GenomeWeb News) - DiscoveRx said yesterday that the National Institutes of Health has agreed to use its PathHunter cell-based assay technology for the NIH Chemical Genomics Center as part of the NIH Molecular Libraries roadmap initiative.


PathHunter is designed for high-throughput screens to monitor cell signaling pathways. The approach has so far been applied to a range of target molecules, including kinases, transcription factors, phosphatases, and nuclear hormone receptors, DiscovRx said.


Financial terms of the agreement were not provided.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.